Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2000
03/23/2000WO1999056773A9 Composition comprising tumor cells and extracts and method of using thereof
03/23/2000WO1999055285A3 Dilating and support apparatus with disease inhibitors and methods for use
03/23/2000WO1999046316A3 Enzyme inhibitors
03/23/2000WO1998015272A8 Method for inhibiting stress-activated protein kinases
03/23/2000DE19844291A1 New aminoalkylaminoalkyl-substituted benzoxazines or benzothiazines, are nitrogen monoxide synthase inhibitors useful for treating neurodegenerative, inflammatory, autoimmune or cardiovascular disease
03/23/2000DE19843489A1 New benzoylguanidine derivatives are Na+/H+ exchange inhibitors, useful for treatment of ischemia and other circulation disorders, tumors, prostatic hypertrophy and diabetic complications
03/23/2000DE19843301A1 Pulverförmige, modifizierte Füllstoffe enthaltende Kautschukpulver, Verfahren zu ihrer Herstellung und Verwendung Powdery, modified fillers containing rubber powder, process for their preparation and use
03/23/2000DE19842963A1 Stable aerosol formulations containing two or more bioactives used for pharmaceuticals
03/23/2000DE19842906A1 Treating male or female sexual dysfunction, especially erectile dysfunction, using propentofylline or corresponding alcohol as selective phosphodiesterase V inhibitor
03/23/2000DE19842766A1 Emulgatorfreie feindisperse Systeme vom Typ Öl-in-Wasser und Wasser-in-Öl Emulsifier-free finely dispersed systems of the oil-in-water and water-in-oil
03/23/2000DE19842753A1 Multiple-unit retard oral dosage formulation having controlled release independent of agitation and food effect, containing particles of combination of drug and hydroxypropyl cellulose
03/23/2000DE19842578A1 Use of nucleosides and nucleobases for reducing thrombocytopenic side effects caused by cytostatic agents, e.g. carboplatin
03/23/2000DE19816732A1 Diagnostik und Therapie von Erkrankungen im Zusammenhang mit HHV-8-Infektionen Diagnosis and treatment of diseases associated with HHV-8 infection
03/23/2000CA2641651A1 Immune activation by double-stranded polynucleotides
03/23/2000CA2344654A1 Regulation of her2/neu oncogene expression by synthetic polyamines
03/23/2000CA2344445A1 Antifungal activity of dicationic molecules
03/23/2000CA2344441A1 Expandible microparticle intracellular delivery system
03/23/2000CA2344401A1 Composition containing natural phenolic compounds for preventing or treating elevated blood lipid level-related diseases
03/23/2000CA2344322A1 Composition containing neohesperidin dihydrochalcone for preventing or treating elevated blood lipid and glucose level-related diseases
03/23/2000CA2344316A1 Treatment of oncologic tumors with an injectable formulation of a golgi apparatus disturbing agent
03/23/2000CA2344309A1 Method for treating diabetes employing an ap2 inhibitor and combination
03/23/2000CA2344300A1 Method for treating atherosclerosis employing an ap2 inhibitor and combination
03/23/2000CA2344054A1 Composition containing rutin and quercetin for preventing or treating elevated blood lipid level-related diseases
03/23/2000CA2344036A1 Pharmacokinetic-based drug design tool and method
03/23/2000CA2343914A1 Method for screening and producing compound libraries
03/23/2000CA2343761A1 Treatment of depression
03/23/2000CA2343760A1 Orally administered controlled drug delivery system providing temporal and spatial control
03/23/2000CA2343654A1 Method for down-regulating osteoprotegerin ligand activity
03/23/2000CA2343574A1 Metabotropic gaba receptor complex issued from the central nervous system
03/23/2000CA2343354A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer
03/23/2000CA2343314A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses
03/23/2000CA2343223A1 Anti-inflammatory and antimicrobial uses for bioactive glass compositions
03/23/2000CA2343205A1 Inhibition of toxic materials or substances using dendrimers
03/23/2000CA2343133A1 Treatment of carcinomas using squalamine in combination with other anti-cancer agents or modalities
03/23/2000CA2342965A1 Leptin induced genes
03/23/2000CA2342608A1 Bioflavonoid as blood glucose level lowering agent
03/23/2000CA2342601A1 Antibodies to c3b(i) for delivery of diagnostic and therapeutic agents to cancer cells
03/23/2000CA2342585A1 A new composition
03/23/2000CA2342583A1 Fused pyridine inhibitors of cgmp phosphodiesterase
03/23/2000CA2342398A1 Moraxella catarrhalis basb034 polypeptides and uses thereof
03/23/2000CA2342341A1 A new composition
03/23/2000CA2342233A1 A new composition
03/23/2000CA2342223A1 A new composition
03/23/2000CA2341767A1 Promotion or inhibition of angiogenesis and cardiovascularization
03/23/2000CA2341683A1 Regulation of lung tissue by hedgehog-like polypeptides, and formulations and uses related thereto
03/23/2000CA2341677A1 Aza-bicycles which modulate the inhibition of cell adhesion
03/23/2000CA2341440A1 Novel compounds
03/23/2000CA2340586A1 T-type calcium channel
03/23/2000CA2339941A1 Use of cyclic esters of r-3-hydroxybutyrate for treatment of metabolic and neural degenerative disorders
03/23/2000CA2339354A1 Compositions comprising sympathomimetic amine salts unsuitable for illegal use
03/23/2000CA2339275A1 5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors
03/23/2000CA2309762A1 Immune activation by double-stranded polynucleotides
03/23/2000CA2281197A1 Active component delivery system comprising a coating structure on which is found a salicylic acid derivative-based composition, and its uses
03/22/2000EP0987552A2 Diarylsulfonylurea binding proteins
03/22/2000EP0987327A1 Novel method for purifying covalently closed circular DNA
03/22/2000EP0987269A1 Salts of optically active sulfoxide derivative
03/22/2000EP0987268A1 Epothilone A-N-oxide, epothilone B-N-oxide, process for their preparation and agent containing same
03/22/2000EP0987267A1 Carbapenem compounds, use thereof, and intermediate compounds of the same
03/22/2000EP0987265A1 Interleukin-5 inhibiting 6-azauracil derivatives
03/22/2000EP0987263A2 Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors
03/22/2000EP0987256A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/22/2000EP0987254A1 Novel cyclic diamine compounds and medicine containing the same
03/22/2000EP0987253A1 Pyrazolone derivatives
03/22/2000EP0987251A1 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines as CETP inhibitors
03/22/2000EP0987248A1 Amide derivatives and their therapeutic use
03/22/2000EP0987029A1 Use of a catonic polymer for the preparation of a complex with nucleic acid and related compositions
03/22/2000EP0987027A1 Physiologically active extract
03/22/2000EP0987024A2 Immunosuppressive agents
03/22/2000EP0987023A1 Transition metal complexes of non steroidal anti-inflammatory drugs
03/22/2000EP0987022A1 Preventives and remedies for ulcerous colitis and/or crohn's disease
03/22/2000EP0987020A1 Metoprolol composition and processes for manufacturing the same
03/22/2000EP0987011A1 Cosmetic and/or dermatological composition containing salicylic acid or its derivatives and its use
03/22/2000EP0987007A2 Emulsifier-free finely dispersed systems of the oil-in-water or water-in-oil type
03/22/2000EP0986963A2 Stable, powdery lycopene formulations containing lycopene with a degree of crystallisation of more than 20%
03/22/2000EP0986637A2 Ribozymes cleaving epidermal growth factor receptors
03/22/2000EP0986581A1 Modified low molecular weight heparin that inhibits clot associated coagulation factors
03/22/2000EP0986580A1 Oligosaccharide mixtures having antithrombotic activity
03/22/2000EP0986574A1 11$g(b)-ARYL SUBSTITUTED 14,17-ETHANO-OESTRATRIENS, METHOD FOR THE PRODUCTION OF THESE COMPOUNDS AND THEIR USE IN THE PRODUCTION OF MEDICAMENTS.
03/22/2000EP0986572A2 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
03/22/2000EP0986570A1 Gemcitabine derivatives
03/22/2000EP0986569A1 Process for preparing etoposide
03/22/2000EP0986568A1 Novel class of nucleic acid cationic transfecting agents
03/22/2000EP0986564A1 6-SUBSTITUTED 1,2,4a,5a,8a,8b HEXAHYDRO- AND 1,2,3,4,4a,5a,8a,8b-OCTAHYDRO-6H-PYRROLO 3',4':4,5]FURO 3,2-b]PYRID-8(7H)-ON DERIVATIVES AND THEIR USE IN COMBATTING ENDOPARASITES
03/22/2000EP0986563A1 2-amino-7-(1-substituted-2-hydroxyethyl)-3,5-dihydro-pyrrolo 3,2-d]pyrimidin-4-ones
03/22/2000EP0986562A1 Substituted 1,2,4-triazolo 3,4-a]phthalazine derivatives as gaba alpha 5 ligands
03/22/2000EP0986561A1 Compounds for inhibition of ceramide-mediated signal transduction
03/22/2000EP0986559A1 1,6-naphthyridine anti-convulsants
03/22/2000EP0986558A2 Ergoline derivatives and their use as somatostatin receptor antagonists
03/22/2000EP0986557A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986556A1 Treatment of central nervous system disorders with selective estrogen receptor modulators
03/22/2000EP0986555A1 Novel phencyclidine derivatives, preparation methods and pharmaceutical compositions containing same
03/22/2000EP0986554A1 Sulfate salt of an hiv protease inhibitor having an improved oral absorption and bioavailability
03/22/2000EP0986553A1 Dihydropyrimidone derivatives as npy antagonists
03/22/2000EP0986552A1 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application
03/22/2000EP0986550A1 Antagonists of gonadotropin releasing hormone
03/22/2000EP0986549A1 Desoxycyclodepsipeptides and their use for combatting endoparasites
03/22/2000EP0986545A1 Non-steroidal (hetero) cyclically substituted acylanilides with mixed gestagen and androgen activity
03/22/2000EP0986544A1 Diphenyl-triazole derivatives and their use as anti-gestative, immuno-suppressant and anti-tumoral agents
03/22/2000EP0986540A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
03/22/2000EP0986539A1 Dna-binding pyrrole and imidazole polyamide derivatives
1 ... 6345 6346 6347 6348 6349 6350 6351 6352 6353 6354 6355 6356 6357 6358 6359 6360 6361 6362 6363 6364 6365 ... 7860